These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6370553)

  • 21. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effects and plasma levels of guanfacine in man.
    Safar ME; Loria Y; Weiss YA; Boutier JR
    J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of clonidine and guanfacine in essential hypertension.
    Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
    Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
    Bazika V
    Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
    Materson BJ; Kessler WB; Alderman MH; Canosa FL; Finnerty FA; Savran SV; McMillen JI; Marlon AM
    Am J Cardiol; 1986 Mar; 57(9):32E-37E. PubMed ID: 3513528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term antihypertensive therapy with guanfacine.
    Szám I; Holló J
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
    Sorkin EM; Heel RC
    Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of chronic guanfacine administration on high plasma vasopressin levels in essential hypertension.
    Berkman K; Tözün N; Taga Y; Dedeoğlu A; Onat F; Bekiroğlu N
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):67-71. PubMed ID: 2407671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J; Schäfer N; Rauh J; Raschig A
    Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
    Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C
    J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A; Kirch W; Lüth B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I; Kállay K
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies of guanfacine and methyldopa.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):55S-59S. PubMed ID: 6994779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study.
    Hauger-Klevene JH; Pinkas MB; Gerber S
    Hypertension; 1981; 3(6 Pt 2):II-222-5. PubMed ID: 7028619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R; Reda G; Spallone L; Anguissola AB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.